Kapil N. Bhalla
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Protein Degradation and Inhibitors, Histone Deacetylase Inhibitors Research, Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked(1997)4,927 cited
- → Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL(2006)1,340 cited
- → Inhibition of Glycolysis in Cancer Cells: A Novel Strategy to Overcome Drug Resistance Associated with Mitochondrial Respiratory Defect and Hypoxia(2005)832 cited
- → Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90(2005)749 cited
- → Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome–positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance(2007)743 cited
- → Microtubule-targeted anticancer agents and apoptosis(2003)458 cited